Pretax income is the income that a company earns before paying income taxes. Prime Medicine's pretax income for the
three
months ended in Mar. 2024 was $-45.63 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-204.44 Mil.
Prime Medicine's pretax margin was -7,720.30%.
During the past 4 years, Prime Medicine's highest Pretax Margin was -29.62%. The lowest was -34592.22%. And the median was -29.62%.
Prime Medicine Pre-Tax Income Historical Data
The historical data trend for Prime Medicine's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Prime Medicine's Pre-Tax Income
For the Biotechnology subindustry, Prime Medicine's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prime Medicine's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Prime Medicine's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Prime Medicine's Pre-Tax Income falls into.
Prime Medicine Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Prime Medicine's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-204.44 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prime Medicine (NAS:PRME) Pre-Tax Income Explanation
Prime Medicine's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 4 years, Prime Medicine's highest Pretax Margin was -29.62%. The lowest was -34592.22%. And the median was -29.62%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prime Medicine Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Prime Medicine's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Prime Medicine (Prime Medicine) Business Description
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRME has been successfully added to your 